Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase a Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer

Cancers - Switzerland
doi 10.3390/cancers11091372
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Pyruvate Kinase M2 and Lactate Dehydrogenase a Are Overexpressed in Pancreatic Cancer and Correlate With Poor Outcome

PLoS ONE
Multidisciplinary
2016English

Shikonin and Its Analogs Inhibit Cancer Cell Glycolysis by Targeting Tumor Pyruvate Kinase-M2

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Pyruvate Kinase M2 Is a Poor Prognostic Marker of and a Therapeutic Target in Ovarian Cancer

PLoS ONE
Multidisciplinary
2017English

Serine Is a Natural Ligand and Allosteric Activator of Pyruvate Kinase M2

Nature
Multidisciplinary
2012English

Determination of Purine Nucleoside Diphosphate by Use of Pyruvate Kinase and Lactate Dehydrogenase.

NIPPON KAGAKU KAISHI
1995English

Pyruvate Kinase M2 Isozyme (PKM2)

Science-Business eXchange
2011English

Pyruvate Kinase M2 Isozyme (PKM2)

Science-Business eXchange
2012English

Long-Term Regulation of Pyruvate Dehydrogenase Complex. Evidence That Kinase-Activator Protein (KAP) Is Free Pyruvate Dehydrogenase Kinase

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1991English

Molecular Association of Glucose-6-Phosphate Isomerase and Pyruvate Kinase M2 With Glyceraldehyde-3-Phosphate Dehydrogenase in Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy